AlphaGene Inc., of Woburn, Mass., added Robert Brown to its scientific advisory board.
AltaRex Corp., of Waltham, Mass., appointed Bruce Brydon and Jacques Lapointe to its board.
Amgen Inc., of Thousand Oaks, Calif., named Brian McNamee senior vice president, human resources and Richard Nanula executive vice president of finance, strategy and communications.
Antex Biologics Inc., of Gaithersburg, Md., appointed Alan Liss vice president, product development.
AP Pharma Inc., of Redwood City, Calif., appointed Jayne Lange vice president, business development.
Aviron Inc., of Mountain View, Calif., elected Barbara Franklin to its board.
British Biotech plc, of Oxford, England, promoted Tim Edwards to chief business officer.
Cephalon Inc., of West Chester, Pa., appointed Charles Sanders to its board.
ChromaVision Medical Systems Inc., of San Juan Capistrano, Calif., named Carl Apfelbach president and chief operating officer.
Cypress Bioscience Inc., of San Diego, formed a fibromyalgia syndrome scientific advisory board consisting of Daniel Clauw, Robert Bennett, Laurence Bradley, Jacques Caldwell, Simon Carette, Don Goldenberg, Daniel Malone, Jon Russell, Daniel Wallace, Arthur Weaver and Muhammad Yunus.
VaxGen Inc., of Brisbane, Calif., added Randall Caudill to its board.
Vertex Pharmaceuticals Inc., of Cambridge, Mass., re-elected Joshua Boger, Charles Sanders and Elaine Ullian as directors.
ViroLogic Inc., of South San Francisco, appointed Edmon Jennings to its board of directors.